Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Novita Healthcare Ltd (NHL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9952
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based software application which can be used to childhood attention difficulties that are prevalent in children with development delay. It has collaborations with Monash University, through which it developed the Tali technology; Grey Innovation, a commercialization technology company and Torus Games, a gaming company. Novita Healthcare operates along with its subsidiaries in Australia, the UK and the US. Novita Healthcare is headquartered in Glen Iris, Victoria, Australia.

Novita Healthcare Ltd (NHL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novita Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novita Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Novita Healthcare Raises USD2 Million in Private Placement of Shares 11
Avexa to Raise USD1.7 Million in Rights Offering of Shares 12
Avexa to Raise Funds through Share Purchase Plan 13
Avexa Raises USD0.3 Million in Private Placement of Shares 14
Avexa to Raise USD3 Million in Private Placement of Shares 15
Avexa Completes Rights Offering Of Shares Of US$1 Million 16
Acquisition 17
Avexa Acquires TALI Health 17
Novita Healthcare Ltd – Key Competitors 18
Novita Healthcare Ltd – Key Employees 19
Novita Healthcare Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Feb 24, 2017: Novita Healthcare: Half year report Period Ending 31 December 2016 21
Corporate Communications 23
Sep 06, 2018: Novita Healthcare strengthens board for growth Sue Macleman appointed new Chair 23
Oct 03, 2017: Novita Appoint New Chief Executive Officer 24
Other Significant Developments 25
Apr 30, 2018: Novita Healthcare: Company Update & Appendix 4C Quarter Ended 31 March 2018 25
Jul 03, 2017: Novita Healthcare: Company Update 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novita Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novita Healthcare Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Novita Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novita Healthcare Raises USD2 Million in Private Placement of Shares 11
Avexa to Raise USD1.7 Million in Rights Offering of Shares 12
Avexa to Raise Funds through Share Purchase Plan 13
Avexa Raises USD0.3 Million in Private Placement of Shares 14
Avexa to Raise USD3 Million in Private Placement of Shares 15
Avexa Completes Rights Offering Of Shares Of US$1 Million 16
Avexa Acquires TALI Health 17
Novita Healthcare Ltd, Key Competitors 18
Novita Healthcare Ltd, Key Employees 19
Novita Healthcare Ltd, Subsidiaries 20

List of Figures
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novita Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novita Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sojitz Corp (2768):企業の財務・戦略的SWOT分析
    Sojitz Corp (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Daewoong Pharmaceutical Co Ltd (069620):企業の財務・戦略的SWOT分析
    Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Nipro Corp (8086):企業の財務・戦略的SWOT分析
    Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Polk-Burnett Electric Cooperative:企業の戦略的SWOT分析
    Polk-Burnett Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Trimble Solutions Oy:企業の戦略的SWOT分析
    Trimble Solutions Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Solid Biosciences Inc (SLDB):製薬・医療:M&Aディール及び事業提携情報
    Summary Solid Biosciences Inc (Solid Biosciences) is a life science company focused on developing therapies for duchenne muscular dystrophy (DMD). Its pipeline product candidates include SGT-001, a microdystrophin gene therapy administered through adeno-associated virus (AAV) stabilizes dystrophin g …
  • Illinois Tool Works Inc.:企業のM&A・事業提携・投資動向
    Illinois Tool Works Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Illinois Tool Works Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Sosei Group Corp (4565):製薬・医療:M&Aディール及び事業提携情報
    Summary Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal agent, administered as a muco-adhe …
  • eLong, Inc.:企業の戦略・SWOT・財務情報
    eLong, Inc. - Strategy, SWOT and Corporate Finance Report Summary eLong, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Texas A&M University-製薬・医療分野:企業M&A・提携分析
    Summary Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences …
  • RXi Pharmaceuticals Corp (RXII):製薬・医療:M&Aディール及び事業提携情報
    Summary RXi Pharmaceuticals Corp (RXi) is a biotechnology company that discovers, develops and commercializes immuno-oncology therapeutics to treat cancer. The company’s technology sd-rxRNA includes RXI-109 and IncRNA. Its lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of …
  • University of Texas Southwestern Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • Dowa Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sumitomo Realty & Development Co., Ltd.
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Avnet, Inc.:戦略・SWOT・企業財務分析
    Avnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Miltenyi Biotec GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulati …
  • WNS (Holdings) Limited:企業の戦略・SWOT・財務情報
    WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆